H.-X. Jin, Y. Wu / Tetrahedron Letters 46 (2005) 6801–6803
6803
2. Porter, N. A.; Caldwell, S. E.; Lowe, J. R. J. Org. Chem.
1998, 63, 5547–5554.
cated and direct treatment with UHP/p-TsOH/DME as
done in the synthesis of 9 led to no peroxy products at
all after one dayꢀs stirring, giving the first sign that the
situation was different in this system. Using PdCl2/
CuCl/DMF–H2O/air/rt10b gave a simpler product mix-
ture, which allowed for separation and identification
of three main components (18, 19, and 20).
3. (a) Griesbeck, A. G.; El-Idreesy, T. T.; Fiege, M.; Brun, R.
Org. Lett. 2002, 4, 4193–4195; (b) McCullough, K. J.;
Nonami, Y.; Masuyama, A.; Nojima, M.; Kim, H.-S.;
Wataya, Y. Tetrahedron Lett. 1999, 40, 9151–9155; (c)
Dussault, P. H.; Eary, C. T.; Lee, R.; Zope, U. R. J. Chem.
Soc., Perkin Trans. 1 1999, 2188–2204.
4. (a) Sels, B. F.; Vos, D. E. D. V.; Grobet, P. J.; Pierard, P.;
Mesmaeker, F. K.; Jacobs, P. A. J. Phys. Chem. B 1999,
103, 11114–11123; (b) Jin, H.-X.; Liu, H.-H.; Wu, Y.-K.
Chin. J. Chem. 2004, 22, 999–1002.
5. (a) Tokuyasu, T.; Masuyama, A.; Nojima, M.; McCul-
lough, K. J. J. Org. Chem. 2000, 65, 1069–1075; (b)
Vennerstrom, J. L.; Arbe-Barnes, S.; Brun, R.; Charman,
S. A.; Chiu, F. C.; Chollet, J.; Dong, Y.; Dorn, A.;
Hunziker, D.; Matile, H.; McIntosh, K.; Padmanilayam,
M.; Santo Tomas, J.; Scheurer, C.; Scorneaux, B.; Tang,
Y.; Urwyler, H.; Wittlin, S.; Charman, W. N. Nature 2004,
430, 900–904; (c) Xu, C.; Raible, J. M.; Dussault, P. H.
Org. Lett. 2005, 7, 2509–2511.
6. (a) Howarth, J.; Wilson, D. Bioorg. Med. Chem. Lett.
2003, 13, 2013–2015; (b) Dussault, P. H.; Trullinger, T. K.;
Noor-e-Ain, F. Org. Lett. 2002, 4, 4591–4593; (c) McCul-
lough, K. J.; Wood, J. K.; Bhattacharjee, A. K.; Dong, Y.;
Kyle, D.; Milhous, W. K.; Vennerstrom, J. L. J. Med.
Chem. 2000, 43, 1246–1249; (d) Kim, H.-S.; Shibata, Y.;
Wataya, Y.; Tsuchiya, K.; Masuyama, K.; Nojima, M.
J. Med. Chem. 1999, 42, 2604–2609.
7. (a) Murakami, N.; Kawanishi, M.; Itagaki, S.; Horii, T.;
Kobayashi, M. Tetrahedron Lett. 2001, 42, 7281–7285; (b)
Murakami, N.; Kawanishi, M.; Itagaki, S.; Horii, T.;
Kobayashi, M. Bioorg. Med. Chem. Lett. 2002, 12, 69–72.
8. Yoshikawa, S.; Odaira, J.-i.; Kitamura, Y.; Bedekar, A.
V.; Furuta, T.; Tanaka, K. Tetrahedron 2004, 60, 2225–
2234.
Treatment of 19 with 7 equiv of UHP and 0.9 equiv of p-
TsOH/DME for three days, however, failed to yield any
expected product. Addition13 of 3 equiv of CSA (10-
camphorsulfonic acid) facilitated the reaction signifi-
cantly. After only 12 h at rt, the desired 21 could be
clearly spotted on TLC, along with some 18 and 20
(which were much more resistant to the hydroperoxida-
tion). In preparative runs, the mixture of 18, 19 and 20
was treated with 13 equiv of UHP and 5 equiv of CSA14
to afford 21 (J = 15.9 Hz for the –CH@CHCO2Et) in
33% yield, together with the recovered 18 and 20 (ca.
67% altogether, which could be recycled).
The final ring closure was also realized with HNEt2/
F3CCH2OH. However, with an additional benzene ring
in the substrate, the Michael addition became much
more difficult. The highest yield of 2215 we could
obtain was only 24%, significantly lower16 than that
for 10. The reason for this unexpected outcome was
not clear yet. Perhaps the p–p interactions between
the benzene rings somehow made it more difficult for
the hydroperoxyl group to approach the C–C double
bond.
In summary, to develop potential antimalarial leads we
have designed and synthesized two novel peroxides that
carry one or two benzene rings fused to a 1,7,8-trioxa-
spiro[5.6]dodecan framework (which may be useful
because of the presence of UV chromophore(s) stable
to hydrolysis and the ability to generate benzyl radicals
on cleavage by single-electron reducing species). CSA
was found to be a potent catalyst for introduction
of the hydroperoxyl group, making a useful comple-
ment to Kobayashiꢀs methodology in constructing
spiroperoxides.
9. Parhem, W. E.; Egberg, D. C. J. Org. Chem. 1972, 37,
1545–1549.
10. (a) Smith, A. B.; Rivero, R. A., III; Hale, K. J.; Vaccaro,
H. A. J. Am. Chem. Soc. 1991, 113, 2092–2112; (b)
Mereyala, H. B.; Guntha, S. Tetrahedron Lett. 1993, 34,
6929–6930; (c) Boss, R.; Scheffold, R. Angew. Chem., Int.
Ed. Engl. 1976, 15, 558–559; (d) Nakayama, K.; Uoto, K.;
Higashi, K.; Soga, T.; Kusama, T. Chem. Pharm. Bull.
1992, 40, 1718–1720.
11. Jin, H.-X.; Liu, H.-H.; Zhang, Q.; Wu, Y.-K. Tetrahedron
Lett. 2005, 46, 5767–5769. Noted that Kobayashi also
examined p-TsOH. However, the yields for the non-cyclic
hemiketal substrates were rather low unless 20-fold excess
of UHP was employed.
12. For spectroscopic data of 10 and 22 (used as starting
materials there) see: Wu, Y.-K.; Jin, H.-X.; Liu, H.-H.;
Zhang, Q. J. Org. Chem. 2005, 70, 4240–4247.
13. We have also tried some other acid catalysts (e.g.,
F3BÆOEt2, F3CCO2H, CH3SO3H), but none of them gave
satisfactory results.
Acknowledgements
This work was supported by the National Natural
Science Foundation of China (20025207, 20272071,
20372075, 20321202), the Chinese Academy of Sciences
(ꢁKnowledge Innovationꢀ project, KGCX2-SW-209),
and the Major State Basic Research Development
Program (G2000077502).
14. In order to dissolve the large excess of UHP and CSA
required for (partially) converting 18 and 20 into 21 some
EtOH must be introduced as a co-solvent.
15. Although the diastereomers of monocyclic peroxides
could be separated,7b most of the spiroperoxides we
prepared appeared as one spot on TLC. Besides, the
separated7b diastereomers showed essentially the same
antimalarial potency. Therefore, we did not make exhaus-
tive efforts (e.g., using HPLC) to separate our
diastereomers.
16. We have also examined some other bases (LiOH, Et3N,
etc.) or extending the reaction time, but none of them led
to better yields.
References and notes
1. (a) Li, Y.; Wu, Y.-L. Curr. Med. Chem. 2003, 10, 2197–
2230; (b) Haynes, R. K.; Vonwiller, S. C. Acc. Chem. Res.
1997, 30, 73–79; (c) OꢀNeill, P. M.; Posner, G. H. J. Med.
Chem. 2004, 47, 2945–2964; (d) Robert, A.; Dechy-
Cabaret, O.; Cazalles, J. M.; Meunier, B. Acc. Chem.
Res. 2002, 35, 167–174.